Condition (MeSH)
Shellfish Hypersensitivity
ClinicalTrials.gov lists 5 trials for Shellfish Hypersensitivity or a narrower condition beneath it. Alladapt Immunotherapeutics, Inc. has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Shellfish Hypersensitivity itself; the rest are tagged with a narrower condition beneath it.
When did Shellfish Hypersensitivity trials start? (5)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 4
- Not applicable
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2024 | 1 |
| 2022 | 1 |
| 2021 | 1 |
| 2014 | 1 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Shellfish Hypersensitivity trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 2 |
| Phase 4 | 1 |
| Not applicable | 2 |
How many Shellfish Hypersensitivity trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 1 |
| Terminated | 1 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Shellfish Hypersensitivity trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Alladapt Immunotherapeutics, Inc. | 2 |
Which serious adverse events do Shellfish Hypersensitivity trials report? (1)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Anaphylaxis | 2 | 1 |
Which publications cover Shellfish Hypersensitivity? (3)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Usefulness of the Nasal Allergen Provocation Test in the Diagnosis of Shellfish Allergy. | Journal of investigational allergology & clinical immunology | 2022 | Yes |
| Safety of chitosan processed wine in shrimp allergic patients. | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2016 | Yes |
| Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy. | The Journal of allergy and clinical immunology | 2015 | No |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.